부신암 진단 시장 규모, 점유율, 성장 분석 : 진단 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Adrenal Cancer Diagnostics Market size was valued at USD 486.2 Million in 2024 and is poised to grow from USD 533.85 Million in 2025 to USD 1127.81 Million by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The global adrenal cancer diagnostics market is witnessing significant growth due to heightened awareness of adrenal tumors and an increasing demand for timely, accurate detection. Rising incidences, particularly of adrenocortical carcinoma, are prompting the adoption of advanced diagnostic techniques. Enhanced imaging technologies, including CT, MRI, and PET scans, allow for earlier identification and more precise tumor characterization and staging. Concurrently, there is a growing reliance on hormonal and biochemical testing to differentiate functional tumors. The advancement of molecular diagnostics and biomarker testing facilitates refined risk assessment and disease categorization. Moreover, increasing healthcare investments, improved access to oncology experts, and the demand for personalized medicine are driving comprehensive testing. Additionally, AI advancements in imaging and workflow optimization are attracting investment and enhancing patient outcomes, expanding market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adrenal Cancer Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adrenal Cancer Diagnostics Market Segments Analysis

The global adrenal cancer diagnostics market is segmented by diagnostic type, technology, application, end user and region. Based on diagnostic type, the market is segmented into Imaging Tests, Blood Tests, Urine Tests and Biopsy. Based on technology, the market is segmented into CT, MRI, PET and Molecular Diagnostics. Based on application, the market is segmented into Initial Diagnosis, Disease Staging and Treatment Monitoring. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories and Cancer Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Adrenal Cancer Diagnostics Market

One of the key market drivers for the global adrenal cancer diagnostics market is the increasing prevalence of adrenal tumors, which has heightened awareness and a demand for early detection and accurate diagnosis. As healthcare providers and patients become more informed about adrenal cancer symptoms and treatment options, the need for advanced diagnostic tools, such as imaging techniques and biomarker testing, has surged. Additionally, technological advancements in diagnostic methodologies, alongside ongoing research efforts aimed at enhancing precision medicine approaches, are fueling market growth by improving diagnostic accuracy and enabling more personalized treatment plans for patients affected by adrenal cancer.

Restraints in the Global Adrenal Cancer Diagnostics Market

The substantial costs associated with advanced adrenal cancer diagnostics, such as sophisticated imaging systems and specialized assay kits, pose a significant financial obstacle for numerous healthcare facilities. Institutions operating under strict budget constraints often defer investments in cutting-edge technologies in favor of more economical alternatives, which may lack the sensitivity required for optimal diagnostics. This cost-related hesitance can impede the integration of newer diagnostic solutions into standard practice, ultimately restricting market growth, despite a rising clinical demand for enhanced accuracy. Additionally, delays in coverage decisions by reimbursement agencies further inhibit adoption in budget-conscious environments.

Market Trends of the Global Adrenal Cancer Diagnostics Market

The Global Adrenal Cancer Diagnostics market is witnessing a significant shift towards precision immuno profiling, driven by the integration of advanced technologies such as multiplex immunohistochemistry and spatial transcriptomics. This innovative approach allows clinicians to analyze the tumor microenvironment of adrenal cortical carcinoma with unprecedented detail, enabling tailored treatment strategies based on individual patient profiles rather than a generic approach. As research collaborations grow and the accessibility of sophisticated assay platforms improves, more laboratories are adopting these cutting-edge tools in their diagnostic practices. This trend underscores a broader movement towards personalized medicine in adrenal cancer care, ultimately enhancing patient outcomes and transforming treatment paradigms.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Adrenal Cancer Diagnostics Market Size by Diagnostic Type & CAGR (2026-2033)

• Market Overview
• Imaging Tests
• Blood Tests
• Urine Tests
• Biopsy

Global Adrenal Cancer Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• CT
• MRI
• PET
• Molecular Diagnostics

Global Adrenal Cancer Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Initial Diagnosis
• Disease Staging
• Treatment Monitoring

Global Adrenal Cancer Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Cancer Centers

Global Adrenal Cancer Diagnostics Market Size & CAGR (2026-2033)

• North America (Diagnostic Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Diagnostic Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnostic Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnostic Type, Technology, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnostic Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations